Chong Kun Dang exports anemia treatment biosimilar 'Nesvel' to 6 Middle Eastern countries
Supply of Nesbel Finished Products to Magazine
[Asia Economy Reporter Kim Ji-hee] Chong Kun Dang announced on the 5th that it has signed an export contract for the second-generation anemia treatment biosimilar 'Nesvel' with Oman’s Manajin.
Manajin is a pharmaceutical company that sells various specialty medicines such as biosimilars and anticancer drugs in the Middle East region and possesses state-of-the-art biopharmaceutical manufacturing facilities in Oman.
Under this contract, Chong Kun Dang will supply finished products of Nesvel to Manajin. It will receive an upfront payment and milestone royalties. Manajin plans to obtain product approval for Nesvel in six Middle Eastern countries including Oman, Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, and Bahrain, and then exclusively sell the product. The contract scale and other details remain confidential by mutual agreement.
Nesvel is a biosimilar of Nesp, with darbepoetin alfa as its main ingredient. It is an effective drug for treating anemia in patients with chronic renal failure. Using genetic engineering technology, it significantly reduces the frequency of drug administration, improving patient convenience as a second-generation sustained-release product. It was launched in Korea and Japan in 2019. Last year, it signed an export contract with Lotus, which handles the Asian region for the global pharmaceutical company Alvogen, and is currently undergoing approval processes in three Southeast Asian countries: Taiwan, Vietnam, and Thailand.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- No Cure Yet, Outbreak Spreads Fast... Already 105 Dead, American Infected
- "It's Only May, but Convenience Stores Know... Iced Americano at 24°C, Tube Ice Cream at 31°C: The Thermometer of the Summer Sales Boom"
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- [Breaking] Chung Yongjin Apologizes for Starbucks 'Tank Day' Controversy: "I Take Full Responsibility"
A Chong Kun Dang official stated, “Nesvel is proving its excellence in the global market as it is exported to the Middle East following Japan and Southeast Asia,” adding, “We will target the global Nesp market including Europe and the United States in the future, while accelerating the development of various biopharmaceuticals.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
